Find Research Outputs

Search concepts
Selected filters
2019
1 Citation (Scopus)

A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancer

Kim, T. Y., Han, H. S., Lee, K. W., Zang, D. Y., Rha, S. Y., Park, Y. I., Kim, J. S., Lee, K. H., Park, S. H., Song, E. K., Jung, S. A., Lee, N. M., Kim, Y. H., Cho, J. Y. & Bang, Y. J., 2019 Nov 1, In : Gastric Cancer. 22, 6, p. 1206-1214 9 p.

Research output: Contribution to journalArticle

Paclitaxel
Stomach Neoplasms
Maximum Tolerated Dose
HM781-36B
Trastuzumab
7 Citations (Scopus)

Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: Phase 1b results from the JAVELIN Solid Tumor trial

Chung, H. C., Arkenau, H. T., Lee, J., Rha, S. Y., Oh, D. Y., Wyrwicz, L., Kang, Y. K., Lee, K. W., Infante, J. R., Lee, S. S., Kemeny, M., Keilholz, U., Melichar, B., Mita, A., Plummer, R., Smith, D., Gelb, A. B., Xiong, H., Hong, J., Chand, V. & 1 others, Safran, H., 2019 Feb 4, In : Journal for ImmunoTherapy of Cancer. 7, 1, 30.

Research output: Contribution to journalArticle

Esophagogastric Junction
Stomach
Maintenance
Disease-Free Survival
Neoplasms
1 Citation (Scopus)

Behaviors and attitudes toward the use of complementary and alternative medicine among Korean cancer patients

Kwon, J. H., Lee, S. C., Lee, M. A., Kim, Y. J., Kang, J. H., Kim, J. Y., Lee, H. J., Bae, W. K., Kim, M. J., Chie, E. K., Kim, J., Kim, Y. H., Chung, H. C. & Rha, S. Y., 2019 Jul 1, In : Cancer Research and Treatment. 51, 3, p. 851-860 10 p.

Research output: Contribution to journalArticle

Open Access
Complementary Therapies
Neoplasms
Republic of Korea
Odds Ratio
Confidence Intervals

Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea

Kim, H. S., Nam, C. M., Jang, S. Y., Choi, S. K., Han, M., Kim, S., Moneta, M. V., Lee, S. Y., Cho, J. M., Novick, D. & Rha, S. Y., 2019 Oct 1, In : Cancer research and treatment : official journal of Korean Cancer Association. 51, 4, p. 1380-1391 12 p.

Research output: Contribution to journalArticle

Open Access
Korea
Sarcoma
Therapeutics
National Health Programs
Incidence

Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer

Park, H. S., Kwon, W. S., Park, S., Jo, E., Lim, S. J., Lee, C. K., Lee, J. B., Jung, M., Kim, H. S., Beom, S. H., Park, J. Y., Kim, T. S., Chung, H. C. & Rha, S. Y., 2019 Oct 21, In : Journal for ImmunoTherapy of Cancer. 7, 1, 268.

Research output: Contribution to journalArticle

Open Access
Immunologic Monitoring
Body Fluids
Stomach Neoplasms
T-Lymphocytes
Vascular Endothelial Growth Factor A
1 Citation (Scopus)

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Graham, J., Wells, J. C., Donskov, F., Lee, J. L., Fraccon, A., Pasini, F., Porta, C., Bowman, I. A., Bjarnason, G. A., Ernst, D. S., Rha, S. Y., Beuselinck, B., Hansen, A., North, S. A., Kollmannsberger, C. K., Wood, L. A., Vaishampayan, U. N., Pal, S. K., Choueiri, T. K. & Heng, D. Y. C., 2019 Nov 1, In : European urology oncology. 2, 6, p. 643-648 6 p.

Research output: Contribution to journalArticle

Open Access
Nephrectomy
Renal Cell Carcinoma
Databases
Survival
Confidence Intervals
Symptom Assessment
Randomized Controlled Trials
Fatigue
Education
Neoplasms
3 Citations (Scopus)

Differences in the efficacies of pazopanib and gemcitabine/docetaxel as second-line treatments for metastatic soft tissue sarcoma

Kim, J. H., Park, H. S., Heo, S. J., Kim, S. K., Han, J. W., Shin, K. H., Kim, S. H., Hur, H., Kim, K. S., Choi, Y. D., Kim, S., Lee, Y. H., Suh, J. S., Ahn, J. B., Chung, H. C., Noh, S. H., Rha, S. Y. & Kim, H. S., 2019 Feb 1, In : Oncology (Switzerland). 96, 2, p. 59-69 11 p.

Research output: Contribution to journalArticle

docetaxel
gemcitabine
Sarcoma
Therapeutics
Synovial Sarcoma
4 Citations (Scopus)
Open Access
Esophagogastric Junction
Gastrointestinal Neoplasms
Stomach
Adenocarcinoma
oxaliplatin

Immunohistochemistry biomarkers predict survival in stage II/III gastric cancer patients: From a prospective clinical trial

Kim, M. H., Zhang, X., Jung, M., Jung, I., Park, H. S., Beom, S. H., Kim, H. S., Rha, S. Y., Kim, H., Choi, Y. Y., Son, T., Kim, H. I., Cheong, J. H., Hyung, W. J., Noh, S. H. & Chung, H. C., 2019 Jan 1, In : Cancer Research and Treatment. 51, 2, p. 819-831 13 p.

Research output: Contribution to journalArticle

Open Access
Thymidylate Synthase
Stomach Neoplasms
oxaliplatin
Biomarkers
Immunohistochemistry
1 Citation (Scopus)

Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancer

Jung, M., Park, K. H., Kim, H. M., Kim, T. S., Zhang, X., Park, S. M., Beom, S. H., Kim, H. S., Cheong, J. H., Chung, H. C., Soong, J., Lin, S. C. & Rha, S. Y., 2019 Nov 1, In : Gastric Cancer. 22, 6, p. 1153-1163 11 p.

Research output: Contribution to journalArticle

Casein Kinase II
Paclitaxel
Stomach Neoplasms
Heterografts
Phosphatidylinositol 3-Kinase
1 Citation (Scopus)

Landscape of actionable genetic alterations profiled from 1,071 tumor samples in Korean cancer patients

Lee, S. H., Lee, B., Shim, J. H., Lee, K. W., Yun, J. W., Kim, S. Y., Kim, T. Y., Kim, Y. H., Ko, Y. H., Chung, H. C., Yu, C. S., Lee, J., Rha, S. Y., Kim, T. W., Jung, K. H., Im, S. A., Moon, H. G., Cho, S., Kang, J. H., Kim, J. & 10 others, Kim, S. K., Ryu, H. S., Ha, S. Y., Kim, J. I., Chung, Y. J., Kim, C., Kim, H. L., Park, W. Y., Noh, D. Y. & Park, K., 2019 Jan 1, In : Cancer Research and Treatment. 51, 1, p. 211-222 12 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Paraffin
Formaldehyde
Precision Medicine
Workflow
4 Citations (Scopus)

Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: Study design and rationale

Grünwald, V., Powles, T., Choueiri, T. K., Hutson, T. E., Porta, C., Eto, M., Sternberg, C. N., Rha, S. Y., He, C. S., Dutcus, C. E., Smith, A., Dutta, L., Mody, K. & Motzer, R. J., 2019 Mar, In : Future Oncology. 15, 9, p. 929-941 13 p.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Therapeutics
Vascular Endothelial Growth Factor A
Disease-Free Survival
Survival Rate
1 Citation (Scopus)

Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer

Shin, S. J., Park, S., Kim, M. H., Nam, C. M., Kim, H., Choi, Y. Y., Jung, M. K., Choi, H. J., Rha, S. Y. & Chung, H. C., 2019 Nov 1, In : Oncologist. 24, 11, p. e1108-e1114

Research output: Contribution to journalArticle

Stomach Neoplasms
Recurrence
Survival
Neoplasms
mesothelin

Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer

Kim, H. S., Koom, W. S., Baek, S. E., Kim, H. I., Jung, M., Beom, S. H., Kang, B., Kim, H., Chang, J. S., Choi, Y. Y., Son, T., Cheong, J. H., Noh, S. H., Kim, E. H., Park, J. C., Shin, S. K., Lee, S. K., Lee, Y. C., Shin, S. J., Chung, H. & 5 others, Jung, I., Chung, H. C., Lim, J. S., Hyung, W. J. & Rha, S. Y., 2019 Nov, In : Radiotherapy and Oncology. 140, p. 143-149 7 p.

Research output: Contribution to journalArticle

Chemoradiotherapy
Stomach Neoplasms
Drug Therapy
docetaxel
Cisplatin

Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer

Kim, C., Chon, H. J., Kim, J. H., Jung, M., Nam, C. M., Kim, H. S., Kang, B., Chung, H. C. & Rha, S. Y., 2019 May, In : European Journal of Cancer. 112, p. 20-28 9 p.

Research output: Contribution to journalArticle

docetaxel
Fluorouracil
Stomach Neoplasms
Paclitaxel
Disease-Free Survival
4 Citations (Scopus)

S-1 based doublet as an adjuvant chemotherapy for curatively resected stage III gastric cancer: Results from the randomized phase III POST trial

Lee, C. K., Jung, M., Kim, H. S., Jung, I., Shin, D. B., Kang, S. Y., Zang, D. Y., Kim, K. H., Lee, M. H., Kim, B. S., Lee, K. H., Cheong, J. H., Hyung, W. J., Noh, S. H., Chung, H. C. & Rha, S. Y., 2019 Jan 1, In : Cancer Research and Treatment. 51, 1, p. 1-11 11 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Cisplatin
Stomach Neoplasms
docetaxel
oxaliplatin

Significance of metabolic tumor volume and total lesion glycolysis measured using18F-FDG PET/CT in locally advanced and metastatic gallbladder carcinoma

Chun, Y. J., Jeung, H. C., Park, H. S., Park, J. S., Rha, S. Y., Choi, H. J., Lee, J. H. & Jeon, T. J., 2019 Jul, In : Yonsei medical journal. 60, 7, p. 604-610 7 p.

Research output: Contribution to journalArticle

Open Access
Gallbladder Neoplasms
Glycolysis
Gallbladder
Tumor Burden
Carcinoma

Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapy

Rha, S., Park, M. & Lee, J., 2019 May 1, In : Supportive Care in Cancer. 27, 5, p. 1687-1695 9 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Fatigue
Appetite
Nausea
cyhalothrin

Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma

Lee, J. B., Park, H. S., Park, S., Lee, H. J., Kwon, K. A., Choi, Y. J., Kim, Y. J., Nam, C. M., Cho, N. H., Kang, B., Chung, H. C. & Rha, S. Y., 2019 Oct 1, In : Cancer research and treatment : official journal of Korean Cancer Association. 51, 4, p. 1578-1588 11 p.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Disease-Free Survival
Confidence Intervals
Survival
Nephrectomy
2 Citations (Scopus)

The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer

Chon, H. J., Kim, C., Cho, A., Kim, Y. M., Jang, S. J., Kim, B. O., Park, C. H., Hyung, W. J., Ahn, J. B., Noh, S. H., Yun, M. & Rha, S. Y., 2019 Jan 22, In : Gastric Cancer. 22, 1, p. 113-122 10 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Histology
Disease-Free Survival
Survival
Signet Ring Cell Carcinoma
1 Citation (Scopus)
Stomach Neoplasms
Quality of Life
Health Information Systems
Depression
Continuity of Patient Care
2018
6 Citations (Scopus)

A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer

Sundar, R., Rha, S. Y., Yamaue, H., Katsuda, M., Kono, K., Kim, H. S., Kim, C., Mimura, K., Kua, L. F. & Yong, W. P., 2018 Mar 27, In : BMC cancer. 18, 1, 332.

Research output: Contribution to journalArticle

Combined Vaccines
Subunit Vaccines
Stomach Neoplasms
Cytotoxic T-Lymphocytes
Cancer Vaccines

A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy

Chae, D., Nam, C. M., Kim, J. H., Lee, C. K., Kim, S. S., Kim, H. S., Jung, M., Cheong, J. H., Chung, H. C., Rha, S. Y. & Park, K., 2018 Jul 1, In : AAPS Journal. 20, 4, 72.

Research output: Contribution to journalArticle

Stomach Neoplasms
Drug Therapy
Survival
Neoplasms
Fluorouracil
1 Citation (Scopus)

Author Correction: Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin (Experimental & Molecular Medicine, (2018), 50, 1, (e435), 10.1038/emm.2017.248)

Jeong, B. Y., Cho, K. H., Jeong, K. J., Park, Y. Y., Kim, J. M., Rha, S. Y., Park, C. G., Mills, G. B., Cheong, J. H. & Lee, H. Y., 2018 Sep 1, In : Experimental and Molecular Medicine. 50, 9, 124.

Research output: Contribution to journalComment/debate

Molecular Medicine
Snails
Integrins
Vascular Endothelial Growth Factor A
Medicine
3 Citations (Scopus)

BGJ398, a pan-FGFR inhibitor, overcomes paclitaxel resistance in urothelial carcinoma with FGFR1 overexpression

Kim, S. H., Ryu, H., Ock, C. Y., Suh, K. J., Lee, J. Y., Kim, J. W., Lee, J. O., Kim, J. W., Kim, Y. J., Lee, K. W., Bang, S. M., Kim, J. H., Lee, J. S., Ahn, J. B., Kim, K. J. & Rha, S. Y., 2018 Oct 15, In : International journal of molecular sciences. 19, 10, 3164.

Research output: Contribution to journalArticle

Fibroblast Growth Factor Receptors
fibroblasts
Fibroblasts
Paclitaxel
inhibitors
1 Citation (Scopus)

Casein kinase 2 inhibitor, CX-4945, as a potential targeted anticancer agent in gastric cancer

Kim, H. M., Jeong, I., Kim, H. J., Kang, S. K., Kwon, W. S., Kim, T. S., Park, K. H., Jung, M., Soong, J., Lin, S. C., Chung, H. C. & Rha, S. Y., 2018 Nov, In : Anticancer research. 38, 11, p. 6171-6180 10 p.

Research output: Contribution to journalArticle

Casein Kinase II
Antineoplastic Agents
Stomach Neoplasms
Cell Line
Exome
5 Citations (Scopus)

CpG island methylator phenotype and methylation of wnt pathway genes together predict survival in patients with colorectal cancer

Kim, S. H., Park, K. H., Shin, S. J., Lee, K. Y., Kim, T. I., Kim, N. K., Rha, S. Y. & Ahn, J. B., 2018 Jul, In : Yonsei medical journal. 59, 5, p. 588-594 7 p.

Research output: Contribution to journalArticle

CpG Islands
Wnt Signaling Pathway
Methylation
Colorectal Neoplasms
Phenotype
4 Citations (Scopus)

Efficacy and safety findings from DREAM: A phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy

Kang, Y. K., Ryu, M. H., Park, S. H., Kim, J. G., Kim, J. W., Cho, S. H., Park, Y. I., Park, S. R., Rha, S. Y., Kang, M. J., Cho, J. Y., Kang, S. Y., Roh, S. Y., Ryoo, B. Y., Nam, B. H., Jo, Y. W., Yoon, K. E. & Oh, S. C., 2018 May 1, In : Annals of Oncology. 29, 5, p. 1220-1226 7 p.

Research output: Contribution to journalArticle

Paclitaxel
Stomach Neoplasms
Safety
Drug Therapy
Disease-Free Survival
4 Citations (Scopus)

Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Jung, M., Ryu, M. H., Oh, D. Y., Kang, M., Zang, D. Y., Hwang, I. G., Lee, K. W., Kim, K. H., Shim, B. Y., Song, E. K., Sym, S. J., Han, H. S., Park, Y. L., Kim, J. S., Lee, H. W., Lee, M. H., Koo, D. H., Song, H. S., Lee, N., Yang, S. H. & 10 others, Choi, D. R., Hong, Y. S., Lee, K. E., Maeng, C. H., Baek, J. H., Kim, S., Kim, Y. H., Rha, S. Y., Cho, J. Y. & Kang, Y. K., 2018 Sep 1, In : Gastric Cancer. 21, 5, p. 819-830 12 p.

Research output: Contribution to journalArticle

Paclitaxel
Stomach Neoplasms
Neoplasms
Disease-Free Survival
Survival
5 Citations (Scopus)

Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor

Kim, H. J., Kang, S. K., Kwon, W. S., Kim, T. S., Jeong, I., Jeung, H. C., Kragh, M., Horak, I. D., Chung, H. C. & Rha, S. Y., 2018 Jul 1, In : International Journal of Cancer. 143, 1, p. 151-159 9 p.

Research output: Contribution to journalArticle

Stomach Neoplasms
Cell Line
Hepatocyte Growth Factor
Proto-Oncogene Proteins c-met
Pharmaceutical Preparations
5 Citations (Scopus)

Genetic alterations among Korean melanoma patients showing tumor heterogeneity: A comparison between primary tumors and corresponding metastatic lesions

Lee, S. H., Kim, J. E., Jang, H. S., Park, K. H., Oh, B. H., Shin, S. J., Chung, K. Y., Roh, M. R. & Rha, S. Y., 2018 Oct 1, In : Cancer Research and Treatment. 50, 4, p. 1378-1387 10 p.

Research output: Contribution to journalArticle

Melanoma
Neoplasms
Genetic Heterogeneity
Mutation
Mutation Rate
9 Citations (Scopus)

Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial

Park, H. S., Kim, H. S., Beom, S. H., Rha, S. Y., Chung, H. C., Kim, J. H., Chun, Y. J., Lee, S. W., Choe, E. A., Heo, S. J., Noh, S. H., Hyung, W. J., Cheong, J. H., Kim, H. I., Son, T., Lim, J. S., Baek, S. E. & Jung, M., 2018 Oct 1, In : Annals of surgical oncology. 25, 11, p. 3222-3230 9 p.

Research output: Contribution to journalArticle

Intra-Abdominal Fat
Subcutaneous Fat
Gastrectomy
Stomach Neoplasms
Body Composition
4 Citations (Scopus)

MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis

Kim, H. S., Chon, H. J., Kim, H., Shin, S. J., Wacheck, V., Gruver, A. M., Kim, J. S., Rha, S. Y. & Chung, H. C., 2018 Jun 15, In : Journal of surgical oncology. 117, 8, p. 1679-1686 8 p.

Research output: Contribution to journalArticle

Liver Neoplasms
Stomach Neoplasms
Stomach
Neoplasm Metastasis
Liver
8 Citations (Scopus)

Multidisciplinary treatment for patients with stage IV gastric cancer: The role of conversion surgery following chemotherapy 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis

Beom, S. H., Choi, Y. Y., Baek, S. E., Li, S. X., Lim, J. S., Son, T., Kim, H. I., Cheong, J. H., Hyung, W., Choi, S. H., Jung, M., Kim, H. S., Jeung, H. C., Chung, H., Rha, S. & Noh, S. H., 2018 Nov 15, In : BMC cancer. 18, 1, 1116.

Research output: Contribution to journalArticle

Stomach Neoplasms
Carcinogenesis
Drug Therapy
Health
Gastrectomy
11 Citations (Scopus)

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

Powles, T., Motzer, R. J., Escudier, B., Pal, S., Kollmannsberger, C., Pikiel, J., Gurney, H., Rha, S. Y., Park, S. H., Geertsen, P. F., Gross-Goupil, M., Grande, E., Suarez, C., Markby, D. W., Arroyo, A., Dean, M., Choueiri, T. K. & George, D., 2018 Sep 11, In : British journal of cancer. 119, 6, p. 663-669 7 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Disease-Free Survival
Survival
Therapeutics
Everolimus
12 Citations (Scopus)

Pazopanib for the treatment of non-clear cell renal cell carcinoma: A single-arm, open-label, multicenter, phase II study

Jung, K. S., Lee, S. J., Park, S. H., Lee, J. L., Lee, S. H., Lim, J. Y., Kang, J. H., Lee, S., Rha, S. Y., Lee, K. H., Kim, H. Y. & Lim, H. Y., 2018 Apr 1, In : Cancer Research and Treatment. 50, 2, p. 488-494 7 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Therapeutics
pazopanib
Safety
Korea
2 Citations (Scopus)

Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11

Kim, H. S., Ryu, M. H., Zang, D. Y., Park, S. R., Han, B., Kang, W. K., Rha, S. Y., Jung, M., Kim, J. S., Kang, B. W., Lee, K. H., Rho, S. Y., Kim, J. H., Kim, K. C., Cho, J. W., Choi, D. R., Lim, H., Kang, H. S., Soh, J. S., Kim, M. J. & 2 others, Seo, J. & Kang, Y. K., 2018 Sep 1, In : Gastric Cancer. 21, 5, p. 802-810 9 p.

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Stomach Neoplasms
Neoplasms
Confidence Intervals
6 Citations (Scopus)

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma

Cho, Y. J., Kim, S. H., Kim, E. K., Han, J. W., Shin, K. H., Hu, H., Kim, K. S., Choi, Y. D., Kim, S., Lee, Y. H., Suh, J. S., Ahn, J. B., Chung, H. C., Noh, S. H., Rha, S. Y., Jung, S. T. & Kim, H. S., 2018 Feb 7, In : BMC cancer. 18, 1, 158.

Research output: Contribution to journalArticle

Histone Code
Sarcoma
Survival
Polycomb Repressive Complex 2
Proteins
8 Citations (Scopus)

Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/snail signaling axis and expression of fascin

Jeong, B. Y., Cho, K. H., Jeong, K. J., Park, Y. Y., Kim, J. M., Rha, S. Y., Park, C. G., Mills, G. B., Cheong, J. H. & Lee, H. Y., 2018 Jan 1, In : Experimental and Molecular Medicine. 50, 1, e435.

Research output: Contribution to journalArticle

Snails
Integrins
Vascular Endothelial Growth Factor A
Cells
Neoplasms
3 Citations (Scopus)

Real-time tumor gene expression profiling to direct gastric cancer chemotherapy: Proof-of-concept "3G" trial

Yong, W. P., Rha, S. Y., Tan, I. B. H., Choo, S. P., Syn, N. L., Koh, V., Tan, S. H., Asuncion, B. R., Sundar, R., So, J. B. Y., Shabbir, A., Tan, C. S., Kim, H. S., Jung, M., Chung, H. C., Ng, M. C. H., Tai, D. W. M., Lee, M. H., Wu, J., Yeoh, K. G. & 1 others, Tan, P., 2018 Nov 1, In : Clinical Cancer Research. 24, 21, p. 5272-5281 10 p.

Research output: Contribution to journalArticle

Gene Expression Profiling
oxaliplatin
Stomach Neoplasms
Drug Therapy
Neoplasms

Reconsideration of sample size and power calculation for overall survival in cancer clinical trials

Jung, I., Ko, H. J., Rha, S. Y. & Nam, C. M., 2018 Dec, In : Contemporary Clinical Trials Communications. 12, p. 90-91 2 p.

Research output: Contribution to journalArticle

Sample Size
Clinical Trials
Neoplasms
Disease-Free Survival

Regulation of proliferation and invasion by the IGF signalling pathway in Epstein-Barr virus-positive gastric cancer

Jeong, I., Kang, S. K., Kwon, W. S., Kim, H. J., Kim, K. H., Kim, H. M., Lee, A., Lee, S. K., Bogenrieder, T., Chung, H. C. & Rha, S. Y., 2018 Dec, In : Journal of Cellular and Molecular Medicine. 22, 12, p. 5899-5908 10 p.

Research output: Contribution to journalArticle

Somatomedins
Human Herpesvirus 4
Stomach Neoplasms
Cell Cycle
Sincalide
1 Citation (Scopus)

Renal cell carcinoma is abrogated by p53 stabilization through transglutaminase 2 inhibition

Lee, S. H., Lee, W. K., Kim, N., Kang, J. H., Kim, K. H., Kim, S. G., Lee, J. S., Lee, S., Lee, J., Joo, J., Kwon, W. S., Rha, S. Y. & Kim, S. Y., 2018 Nov 19, In : Cancers. 10, 11, 455.

Research output: Contribution to journalArticle

Streptonigrin
Renal Cell Carcinoma
Mass Spectrometry
Apoptosis
Small Molecule Libraries
1 Citation (Scopus)

Retrospective analysis of palliative chemotherapy for the patients with bladder adenocarcinoma: Korean cancer study group genitourinary and gynecology cancer committee

Kim, M. J., Kim, Y. S., Oh, S. Y., Lee, S., Choi, Y. J., Seol, Y. M., Park, M. J., Kim, K. H., Park, L. C., Kang, J. H., Hwang, I. G., Lee, S. I., Lim, S. T., Kim, H. S., Lim, H. Y., Rha, S. Y. & Kim, H. J., 2018 Mar, In : Korean Journal of Internal Medicine. 33, 2, p. 383-390 8 p.

Research output: Contribution to journalArticle

Urogenital Neoplasms
Gynecology
Urinary Bladder
Adenocarcinoma
Drug Therapy
8 Citations (Scopus)

Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

Guo, J., Jin, J., Oya, M., Uemura, H., Takahashi, S., Tatsugami, K., Rha, S. Y., Lee, J. L., Chung, J., Lim, H. Y., Wu, H. C., Chang, Y. H., Azad, A., Davis, I. D., Carrasco-Alfonso, M. J., Nanua, B., Han, J., Ahmad, Q. & Motzer, R., 2018 May 22, In : Journal of Hematology and Oncology. 11, 1, 69.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Safety
Therapeutics
sunitinib
pazopanib

'Screening audit' as a quality assurance tool in good clinical practice compliant research environments

Park, S., Nam, C. M., Park, S., Noh, Y. H., Ahn, C. R., Yu, W. S., Kim, B. K., Kim, S. M., Kim, J. S. & Rha, S. Y., 2018 Apr 25, In : BMC Medical Ethics. 19, 1, 30.

Research output: Contribution to journalArticle

research practice
quality assurance
audit
Research
Compliance

The Benefit of Pro Re Nata Antiemetics Provided with Guideline-Consistent Antiemetics in Delayed Nausea Control

Rha, S. Y., Sohn, J., Kim, G. M., Kim, H. R. & Lee, J., 2018 Mar 1, In : Cancer Nursing. 41, 2, p. E49-E57

Research output: Contribution to journalArticle

Antiemetics
Nausea
Guidelines
Quality of Life
Incidence
1 Citation (Scopus)

The Comparison of Exosome and Exosomal Cytokines between Young and Old Individuals with or without Gastric Cancer

Im, K., Baek, J., Kwon, W. S., Rha, S., Hwang, K. W., Kim, U. & Min, H., 2018 Sep 1, In : International Journal of Gerontology. 12, 3, p. 233-238 6 p.

Research output: Contribution to journalArticle

Exosomes
Stomach Neoplasms
Cytokines
Serum
Neoplasms
3 Citations (Scopus)

The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status

Park, J. S., Lee, N., Beom, S. H., Kim, H. S., Lee, C. K., Rha, S. Y., Chung, H. C., Yun, M., Cho, A. & Jung, M., 2018 Mar 1, In : Gastric Cancer. 21, 2, p. 213-224 12 p.

Research output: Contribution to journalArticle

Fluorodeoxyglucose F18
Stomach Neoplasms
Tumor Burden
Disease-Free Survival
Survival